뒤로
Healios KK(HLOSF) 가격
HLOSF 주가 차트
HLOSF 배당금
Healios KK
$2.1
0%
$0
종가: Jan 23, 16:00:00 GMT-5
$2.1
0%
$0
애프터마켓: Jan 23, 20:00:00 GMT-5
주요 통계
이전 종가
$2.1
시가
$2.1
일일 범위
$2.1 - $2.1
52주 범위
$0.96 - $4.45
거래량
200
평균 거래량
153
EPS(TTM)
-0.38
배당수익률
--
시가총액
$242.4M
HEALIOS K K란 무엇인가요?
Healios KK engages in the research, development, and sale of cellular and regenerative medicine. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 65 full-time employees. The company went IPO on 2015-06-16. The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.
